Your browser doesn't support javascript.
loading
Treatment of In-Stent Stenosis Following Flow Diversion of Intracranial Aneurysms with Cilostazol and Clopidogrel.
Dowlati, Ehsan; Pasko, Kory B Dylan; Liu, Jiaqi; Miller, Charles A; Felbaum, Daniel R; Sur, Samir; Chang, Jason J; Liu, Ai-Hsi; Armonda, Rocco A; Mai, Jeffrey C.
Afiliação
  • Dowlati E; Department of Neurosurgery, MedStar Georgetown University Hospital, Washington, DC, USA.
  • Pasko KBD; Georgetown University School of Medicine, Washington, DC, USA.
  • Liu J; Georgetown University School of Medicine, Washington, DC, USA.
  • Miller CA; Division of Neurosurgery, Walter Reed National Military Medical Center, Bethesda, MD, USA.
  • Felbaum DR; Department of Neurosurgery, MedStar Georgetown University Hospital, Washington, DC, USA.
  • Sur S; Department of Neurosurgery, MedStar Washington Hospital Center, Washington, DC, USA.
  • Chang JJ; Department of Neurosurgery, MedStar Georgetown University Hospital, Washington, DC, USA.
  • Liu AH; Department of Neurosurgery, MedStar Washington Hospital Center, Washington, DC, USA.
  • Armonda RA; Department of Critical Care Medicine, MedStar Washington Hospital Center, Washington, DC, USA.
  • Mai JC; Department of Radiology, MedStar Washington Hospital Center, Washington, DC, USA.
Neurointervention ; 16(3): 285-292, 2021 Nov.
Article em En | MEDLINE | ID: mdl-34503310
ABSTRACT
In-stent stenosis is a feared complication of flow diversion treatment for cerebral aneurysms. We present 2 cases of patients treated with pipeline flow diversion for unruptured cerebral aneurysms. Initial perioperative dual antiplatelet therapy (DAPT) consisted of standard aspirin plus clopidogrel. At 6-month follow-up cerebral angiography, the patients were noted to have developed significant in-stent stenosis (63% and 53%). The patients were treated with cilostazol and clopidogrel for at least 6 months. Subsequent angiography at 1-year post-treatment showed significant improvement of the in-stent stenosis from 63% to 34% and 53% to 21%. The role of cilostazol as treatment of intracranial in-stent stenosis has not been previously described. Cilostazol's vasodilatory effect and suppression of vascular smooth muscle proliferation provides ideal benefits in this setting. Cilostazol plus clopidogrel may be a safe and effective alternative to standard DAPT for treatment of in-stent stenosis following flow diversion and warrants further consideration and investigation.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article